Halog


Also found in: Wikipedia.

halcinonide

(hal-sin-oh-nide) ,

Halog

(trade name)

Classification

Therapeutic: anti inflammatories steroidal
Pharmacologic: corticosteroids
Pregnancy Category: C

Indications

Management of inflammation and pruritis associated with various allergic and immunologic skin problems.

Action

Suppresses normal immune response and inflammation.

Therapeutic effects

Suppression of dermatologic inflammation and immune processes.

Pharmacokinetics

Absorption: Minimal. Prolonged use on large surface areas or large amounts applied or use of occlusive dressings may increase systemic absorption.
Distribution: Remains primarily at site of action.
Metabolism and Excretion: Usually metabolized in skin.
Half-life: Unknown.

Time/action profile (response depends on condition being treated)

ROUTEONSETPEAKDURATION
Topicalmin–hrshrs–dayshrs–days

Contraindications/Precautions

Contraindicated in: Hypersensitivity or known intolerance to corticosteroids or components of vehicles (ointment or cream base, preservative, alcohol); Untreated bacterial or viral infections.
Use Cautiously in: Hepatic dysfunction; Diabetes mellitus, cataracts, glaucoma, or tuberculosis (use of large amounts of high-potency agents may worsen condition); Patients with pre-existing skin atrophy; Pregnancy, lactation, or children (chronic high-dose usage may result in adrenal suppression in mother and, growth suppression in children; children may be more susceptible to adrenal and growth suppression).

Adverse Reactions/Side Effects

Dermatologic

  • allergic contact dermatitis
  • atrophy
  • burning
  • dryness
  • edema
  • folliculitis
  • hypersensitivity reactions
  • hypertrichosis
  • hypopigmentation
  • irritation
  • maceration
  • miliaria
  • perioral dermatitis
  • secondary infection
  • striae

Miscellaneous

  • adrenal suppression (use of occlusive dressings, long-term therapy)

Interactions

Drug-Drug interaction

None significant.

Route/Dosage

Topical (Adults) Apply to affected area(s) 1–3 times daily (depends on product, preparation, and condition being treated).
Topical (Children) Apply to affected area(s) once daily.

Availability

Cream: 0.025%, 0.1%
Ointment: 0.1%

Nursing implications

Nursing assessment

  • Assess affected skin before and daily during therapy. Note degree of inflammation and pruritus. Notify physician or other health care professional if symptoms of infection (increased pain, erythema, purulent exudate) develop.
  • Lab Test Considerations: Periodic adrenal function tests may be ordered to assess degree of hypothalamic-pituitary-adrenal (HPA) axis suppression in chronic topical therapy if suspected. Children and patients with dose applied to a large area, using an occlusive dressing, or using high-potency products are at highest risk for HPA suppression.
    • May cause increased serum and urine glucose concentrations if significant absorption occurs.

Potential Nursing Diagnoses

Risk for impaired skin integrity (Indications)
Risk for infection (Side Effects)
Deficient knowledge, related to medication regimen (Patient/Family Teaching)

Implementation

  • Choice of vehicle depends on site and type of lesion. Ointments are more occlusive and preferred for dry, scaly lesions. Creams should be used on oozing or intertriginous areas, where the occlusive action of ointments might cause folliculitis or maceration. Creams may be preferred for aesthetic reasons even though they may be more drying to skin than ointments. Solution is useful in hairy areas.
  • Topical: Apply ointment or cream sparingly as a thin film to clean, slightly moist skin. Wash hands immediately after application. Apply occlusive dressing only if specified by physician or other health care professional.

Patient/Family Teaching

  • Instruct patient on correct technique of medication administration. Emphasize importance of avoiding the eyes. If a dose is missed, it should be applied as soon as remembered unless almost time for the next dose.
  • Caution patient to use only as directed. Avoid using cosmetics, bandages, dressings, or other skin products over the treated area unless directed by health care professional.
  • Advise parents of pediatric patients not to apply tight-fitting diapers or plastic pants on a child treated in the diaper area; these garments work like an occlusive dressing and may cause more of the drug to be absorbed.
  • Caution women that medication should not be used extensively, in large amounts, or for protracted periods if they are pregnant or planning to become pregnant.
  • Advise patient to consult health care professional before using medicine for condition other than indicated.
  • Instruct patient to inform health care professional if symptoms of underlying disease return or worsen or if symptoms of infection develop.

Evaluation/Desired Outcomes

  • Resolution of skin inflammation, pruritus, or other dermatologic conditions.

Halog

(hăl′ŏg′)
A trademark for the drug halcinonide.

Halog

a trademark for a topical glucocorticoid (halcinonide).
Mentioned in ?
References in periodicals archive ?
Classic Chinese philosophy, such as Confucianism and Taoism, contains the fundamental idea of sustainability (Li, Cheng, Beeton, Sigler & Halog, 2015).
Cymbalta Antidepressant May cause platelet dysfunction Nexium Proton pump inhibitor Xerostomia Klor-Con Electrolyte supplement None reported Slo-Mag Supplement Vitamin D Supplement None reported Halog Corticosteroid None reported Pramipexole Anti-Parkinson's agent Xerostomia, dysphagia Ferrous sulfate Iron salt Staining with use of liquid version Vitamin B complex Vitamin None reported
Halog, (2009) in their research assessed the potential environmental life cycle impacts and resource consumptions in producing woodchips for biofuels production in Maine, USA.
The home of Edgar Halog, 44, a jeepney driver, was destroyed in the floods and he was sheltering at the centre with his wife and seven children aged between three and 12.
The agreement provides for Medicis to receive a quarterly fee for detailing two Westwood-Squibb brands, HALOG (halcinonide) and DESQUAM (benzoyl peroxide), to dermatologists nationwide.
HALOG is a high-potency topical steroid, important in the treatment of inflammatory conditions of the skin such as psoriasis and eczema.
The facility was built by HaLog GmbH Rastatt, a German builder known for their design of high-technology logistic and distribution facilities.